MEDX.SWMEDX.SWSIX
Loading
EBITDA Over TimeStable
Percentile Rank57
3Y CAGR+5.3%
5Y CAGR+5.5%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+5.3%/yr
vs -9.7%/yr prior
5Y CAGR
+5.5%/yr
Consistent
Acceleration
+14.9pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
2025$79.70M+17.9%
2024$67.60M-1.2%
2023$68.40M+0.1%
2022$68.30M-38.2%
2021$110.60M+81.6%
2020$60.90M-24.0%
2019$80.10M-21.9%
2018$102.50M-